Hollie Grant

Company: Takeda Pharmaceutical

Job title: Director, Global Sustainability

Seminars:

Panel Discussion: Strategic ESG Reporting in the Interim – Making the Most of the Next Few Years Amid Regulatory Ambiguity 12:40 pm

• Discovering how to maintain momentum in ESG reporting and decision-making despite uncertainty around CSRD timelines, the Omnibus bill, and shifting U.S. policies • Exploring strategies for resourcing “light” vs “robust” reports, and learn how to prioritize data and systems investment for long-term value • Learning how to use the lead-up to 2028 as a…Read more

day: Conference Day Two

Navigating the ESG Inflection Point: Aligning 2025 U.S. Policy Shifts & Reporting Rollbacks With Business-Driven Sustainability Goals 9:00 am

• Examining how the current U.S. administration’s evolving ESG stance and delayed reporting requirements are reshaping expectations for transparency, accountability, and long-term goal setting • Understanding how companies are reassessing 2025-aligned strategies to develop 2030-ready ESG frameworks rooted in core business KPIs • Learning how leading organizations are rethinking disclosure practices, stakeholder expectations, and evolving…Read more

day: Workshop A